Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Infectious Disease Caused by SARS-CoV-2”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Large-scale testing (Phase 3)UnknownNCT04386850
What this trial is testing

Oral 25-hydroxyvitamin D3 and COVID-19

Who this might be right for
COVID 19
Tehran University of Medical Sciences 1,500
Not applicableUnknownNCT04326114
What this trial is testing

Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19

Who this might be right for
Disease, InfectiousRespiratory DiseaseSafety Issues+1 more
Universidad Complutense de Madrid 240
Not applicableActive Not RecruitingNCT05697068
What this trial is testing

Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos

Who this might be right for
SARS-CoV-2 Infection
San Diego State University 256
Large-scale testing (Phase 3)UnknownNCT04640233
What this trial is testing

Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection

Who this might be right for
COVID-19 Prevention
Dr. Reddy's Laboratories Limited 1,600
Post-approval studies (Phase 4)Study completedNCT04652648
What this trial is testing

Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts

Who this might be right for
Covid19HydroxychloroquineCoronavirus Infection+2 more
Bryn Mawr Hospital 54
Large-scale testing (Phase 3)UnknownNCT06068569
What this trial is testing

Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Early research (Phase 1)Ended earlyNCT04526912
What this trial is testing

Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection

Who this might be right for
Acute Lung Injury
Viela Bio 10
Large-scale testing (Phase 3)WithdrawnNCT04842331
What this trial is testing

PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)

Who this might be right for
Respiratory Viral InfectionRespiratory Tract DiseasesCOVID-19 Respiratory Infection
Thirty Respiratory Limited
Large-scale testing (Phase 3)Ended earlyNCT04721535
What this trial is testing

DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

Who this might be right for
Covid19SARS-COV-2 Infection
Daewoong Pharmaceutical Co. LTD. 9
Testing effectiveness (Phase 2)Study completedNCT05175833
What this trial is testing

Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19

Who this might be right for
COVID-19 Lower Respiratory InfectionMicrobial ColonizationSevere COVID-19+1 more
Universidade de Passo Fundo 70
Not applicableStudy completedNCT04420260
What this trial is testing

Primary Prevention of Infection by COVID-19 in Workers

Who this might be right for
COVID
Unidad de Investigación Genética Molecular 152
Large-scale testing (Phase 3)UnknownNCT04530396
What this trial is testing

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19

Who this might be right for
Covid19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 33,758
Testing effectiveness (Phase 2)Ended earlyNCT04435808
What this trial is testing

Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

Who this might be right for
COVID-19
University of New Mexico 1
Not applicableStudy completedNCT04765540
What this trial is testing

The Effect of Behaviour Change Interventions on Use of Public Handwashing Stations in Bangladesh

Who this might be right for
Hand WashingHandwashingCovid19
The Behavioural Insights Team 855
Large-scale testing (Phase 3)WithdrawnNCT04452643
What this trial is testing

Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel

Who this might be right for
Covid19
Inmunotek S.L.
Not applicableStudy completedNCT05135455
What this trial is testing

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA

Who this might be right for
Prevention of Infectious Disease Caused by SARS-CoV-2
AstraZeneca 467
Testing effectiveness (Phase 2)UnknownNCT04713488
What this trial is testing

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Who this might be right for
COVID-19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Testing effectiveness (Phase 2)Study completedNCT05381454
What this trial is testing

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

Who this might be right for
Respiratory Viral InfectionAntiviral TreatmentCOVID-19
University of California, Los Angeles 80
Large-scale testing (Phase 3)UnknownNCT04858633
What this trial is testing

Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19

Who this might be right for
Covid19COVID-19 Prevention
Post Graduate Institute of Medical Education and Research, Chandigarh 1,000
Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Next Page